Botulinum toxin assessment, intervention and after-care for upper limb hypertonicity in adults: international consensus statement.
about
Pharmacological interventions other than botulinum toxin for spasticity after strokeMultidisciplinary rehabilitation following botulinum toxin and other focal intramuscular treatment for post-stroke spasticityNon pharmacological interventions for spasticity in multiple sclerosisMultidisciplinary rehabilitation following botulinum toxin and other focal intramuscular treatment for post-stroke spasticitySafety and efficacy of incobotulinumtoxinA as a potential treatment for poststroke spasticityA systematic review protocol to evaluate the psychometric properties of measures of function within adult neuro-rehabilitationUpper limb international spasticity study: rationale and protocol for a large, international, multicentre prospective cohort study investigating management and goal attainment following treatment with botulinum toxin A in real-life clinical practiceIncidence estimate and guideline-oriented treatment for post-stroke spasticity: an analysis based on German statutory health insurance data.Physical therapies as an adjunct to Botulinum toxin-A injection of the upper or lower limb in adults following neurological impairment.Use of botulinum toxin type A in the management of patients with neurological disorders: a national surveyAbo-, inco-, ona-, and rima-botulinum toxins in clinical therapy: a primer.Systematic review of upper-limb function measurement methods in botulinum toxin intervention for focal spasticity.The efficacy of Botulinum Toxin A for spasticity and pain in adults: a systematic review and meta-analysis using the Grades of Recommendation, Assessment, Development and Evaluation approach.Spasticity after stroke: physiology, assessment and treatment.Botulinum toxin for neuropathic pain and spasticity: an overview.The efficacy of Botulinum Toxin A on improving ease of care in the upper and lower limbs: a systematic review and meta-analysis using the Grades of Recommendation, Assessment, Development and Evaluation approach.The effectiveness of therapy on outcome following (BoNT-A) injection for focal spasticity in adults with neurological conditions: A systematic review.Therapeutic use of botulinum toxin in neurorehabilitation.The efficacy of Botulinum Toxin A for limb spasticity on improving activity restriction and quality of life: a systematic review and meta-analysis using the GRADE approach.Pharmacological interventions other than botulinum toxin for spasticity after stroke.Benefits and Risks of Non-Approved Injection Regimens for Botulinum Toxins in Spasticity.Quantifying patterns of upper limb motor change following BTX-A injection in adult spasticity management.Medication, rehabilitation and health care consumption in adults with cerebral palsy: a population based study.A prospective, multicentre, randomized, double-blind, placebo-controlled trial of onabotulinumtoxinA to treat plantarflexor/invertor overactivity after stroke.The use of botulinum toxin type A in the management of adult-onset focal spasticity: a survey of Australian allied health professionals.Frequency and characteristics of goal attainment following BoNT-A injection for management of spasticity.A survey of the current practice of intramuscular Botulinum toxin injections for hemiplegic shoulder pain in the UK.Ankle plantarflexor spasticity is not differentially disabling for those who are weak following traumatic brain injury.Initial psychometric evaluation of the Arm Activity Measure (ArmA): a measure of activity in the hemiparetic arm.Test-retest reliability of computerised hand dynamometry in adults with acquired brain injury.Goal Attainment Scaling in Individuals with Upper Limb Spasticity Post Stroke.Effects of repeated abobotulinumtoxinA injections in upper limb spasticity.Effects of botulinum toxin A therapy and multidisciplinary rehabilitation on lower limb spasticity classified by spastic muscle echo intensity in post-stroke patients.Dynamic decomposition of motion in essential and parkinsonian tremor.Effectiveness of botulinum toxin injection with and without needle electromyographic guidance for the treatment of spasticity in hemiplegic patients: a randomized controlled trial.Long-term effects of injection of botulinum toxin type A combined with home-based functional training for post-stroke patients with spastic upper limb hemiparesis.Effects of botulinum toxin A therapy and multidisciplinary rehabilitation on upper and lower limb spasticity in post-stroke patients.Adhesive taping vs. daily manual muscle stretching and splinting after botulinum toxin type A injection for wrist and fingers spastic overactivity in stroke patients: a randomized controlled trial.Upper limb spasticity management for patients who have received Botulinum Toxin A injection: Australian therapy practice.Effect of early use of AbobotulinumtoxinA after stroke on spasticity progression: Protocol for a randomised controlled pilot study in adult subjects with moderate to severe upper limb spasticity (ONTIME pilot).
P2860
Q24201130-0B20BE80-CB8C-41B7-A83F-D2419F2A7EFEQ24202197-D9FC16FD-6D04-4F2C-8B5F-6811A63C915EQ24202441-E287E3A4-1B5D-4277-A005-19FD5DCE31B1Q24203617-3BB12718-9A6F-4F26-9BD6-912CAF59A1DEQ26766544-0447A60B-21D8-40FA-A7C8-1D0C5CBC5373Q28082115-51AF70BE-D649-47C3-AD18-C5423B6F0009Q30538210-E29F65D1-9292-4E47-9869-EFF466C9726AQ30604640-0BB698F2-22F4-4D4D-9ED9-045E95D94772Q36209475-00997B2C-70B8-4F46-93BB-D3399F197C0FQ37632889-1F792C85-766E-4214-BAC8-C3997AB572A0Q38080776-23CD233A-D7CE-43DD-AD19-E96DC7CD916FQ38102959-1315D74C-207B-4CBE-893E-D833A5E3571CQ38122349-BC4370F4-2B01-4944-9D70-8173BE40403AQ38124046-564C35A5-D09B-4A73-83A4-7B4CE35ECA14Q38196928-25B4853C-3B44-4060-AEA5-0EE9FA3AEFC1Q38263487-3A443C74-7735-4C26-9E02-2540F81EFA31Q38397501-2D708A3B-8911-43E3-ADC0-38ADEEC1E304Q38414925-38605792-8E91-4EF3-8C12-767AA23B3AD0Q38543439-DD62EAE4-9C78-43E9-931A-BA9BC01FB744Q38973681-D65D70E3-DD74-4975-87DF-F163ADD5F472Q39446871-72DC7C59-F558-4B02-B81A-97C462BC374CQ40609751-E759478E-81F1-4D29-92C5-A8A11936AC90Q40629279-77E6B59D-C29F-44BC-BE03-76FB4AAC2F23Q42635046-E492B96B-9C66-4A15-9C67-494FBEA325D1Q45945324-FF060466-F880-4A02-879D-27515A8878AFQ47585173-6BB7C477-D16B-473A-9A32-91B5E116BF2CQ47616836-E59D5302-3AA7-47B3-9367-599FF3A96634Q48028580-0DF77FB7-661B-48C7-9346-EA45D02B7A37Q48155657-75B55F42-B7A2-42C7-833A-F5CDDB3DDCF8Q48393798-658DBD40-C5CE-4DC9-8FCF-5CB39C450853Q48785734-4DB56742-0534-4DAB-BFBD-D2DDE753151AQ49218658-56AF1898-A733-4087-AD64-B63D1AFEF851Q49554112-57FB0730-7F37-4B7F-BFD8-F216A3DF0678Q50245589-C9D56EA6-FA3A-4FF6-89C8-979B0F6C7CF6Q50854451-FC84246B-D984-4BD6-B649-22A161C48C11Q50953981-F070095E-3715-4639-8E70-89DB00C72D7FQ51723052-7C3ACA60-CE1C-4F5D-87C0-1CABA45BFEBFQ53528429-3D1201E4-C6DD-4444-806C-61C823CC4458Q53620293-B6622634-DA06-44F4-A1A3-BF04391AAD5EQ54997236-FB369EE6-C934-49BE-9D65-D54E14306B6E
P2860
Botulinum toxin assessment, intervention and after-care for upper limb hypertonicity in adults: international consensus statement.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Botulinum toxin assessment, in ...... rnational consensus statement.
@en
Botulinum toxin assessment, in ...... rnational consensus statement.
@nl
type
label
Botulinum toxin assessment, in ...... rnational consensus statement.
@en
Botulinum toxin assessment, in ...... rnational consensus statement.
@nl
prefLabel
Botulinum toxin assessment, in ...... rnational consensus statement.
@en
Botulinum toxin assessment, in ...... rnational consensus statement.
@nl
P2093
P2860
P1476
Botulinum toxin assessment, in ...... ernational consensus statement
@en
P2093
Cerebral Palsy Institute
L Turner-Stokes
P2860
P356
10.1111/J.1468-1331.2010.03129.X
P478
17 Suppl 2
P577
2010-08-01T00:00:00Z